US Insurers Must Disclose Rx Pricing, Cost Sharing To Members Under Proposed Rule
Executive Summary
Proposal from the Trump Administration seeks comment on whether the relationship between payers and pharmacy benefit managers would allow disclosure of rate information for drugs.